Heritage Global Reports Q3 2026 Revenue Growth Amid Strategic Shift to Asset-Light Model
Heritage Global (HGBL) reported third-quarter 2026 revenue of $14.6 million, a significant increase from the $11.4 million recorded in the same period last year. Net income rose to $1 million ($0.03 per diluted share), up from $600,000 ($0.02 per diluted share) in Q3 2025. Despite revenue growth, consolidated operating income and adjusted EBITDA saw year-over-year declines due to shifts in financial asset operating income. The company is currently undergoing a strategic transition, winding down its legacy HGP specialty lending business—which management described as a distraction—to focus on asset-light sectors. This includes a $2 million joint venture investment to acquire two pharmaceutical sites in Colorado. While the Boston Note acquisition exceeded goals, DebtX underperformed due to delays in monetizing commercial real estate loans. Management expects a growing pipeline of auction assets through 2027 driven by recent corporate restructuring trends.
Coverage
- Informa TechTarget expects $80M-$85M adjusted EBITDA for 2026 amid slower pipeline conversion
- Heritage Global Reports Q3 2026 Revenue Growth Amid Strategic Shift to Asset-Light Model
- Brookfield Business Reports Q3 2026 Earnings Growth and Strategic Asset Dispositions
- Rayonier Reports Q3 2026 Earnings Boosted by PotlatchDeltic Merger and Asset Dispositions
- Strategic Education expects $50M of 2027 growth investments while consolidated revenue is seen flat
- OPKO Health Reports Q3 2026 Revenue Growth and Completes BioReference Asset Sale
- OPKO Health Projects FY 2026 Revenue of $268M-$278M Following LabCorp Asset Sale